Bacteria News and Research

RSS

Organs actively fighting back against autoimmune diseases, finds study

Organs affected by autoimmune disease could be fighting back by "exhausting" immune cells that cause damage using methods similar to those used by cancer cells to escape detection, according to a study by researchers at the University of Pittsburgh School of Medicine published today in the Journal of Clinical Investigation.

25 Sep 2018

Blood-brain barrier can be important biomarker for early diagnosis of Alzheimer's disease

USC scientists say Alzheimer's could be diagnosed earlier if scientists focus on an early warning within the brain's circulation system.

25 Sep 2018

Genomic ‘islands’ evolved from viruses can be converted into ‘anti-bacterial drones’

Genomic "islands" that evolved from viruses can be converted into "drones" that disable Staphylococcus aureus, bacteria that are often resistant to antibiotics and pose a threat to safe hospital care, a new study finds.

25 Sep 2018

Harmful H. pylori may play a role in Parkinson's disease

While human genetic mutations are involved in a small number of Parkinson's disease (PD) cases, the vast majority of cases are of unknown environmental causes, prompting enormous interest in identifying environmental risk factors involved.

25 Sep 2018

TU Wien develops new remedy for celiac disease

Celiac disease is a fairly common disease, affecting one to two percent of the European population. It is expressed as a hypersensitivity to gluten, a protein found in cereals such as wheat, barley or rye.

24 Sep 2018

New test speeds up diagnosis of multi-resistant pathogens

Researchers at the University of Cologne and the German Center for Infection Research have made an important step towards speeding up the diagnosis of multi-resistant pathogens.

24 Sep 2018

Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD

Alexion Pharmaceuticals, Inc. today announced positive topline results from the Phase 3 PREVENT study of Soliris in patients with anti-aquaporin-4 auto antibody-positive neuromyelitis optica spectrum disorder.

24 Sep 2018

Pioneering procedure for common prostate condition offered by The London Clinic

The London Clinic is one of the first hospitals in the UK to offer prostate artery embolization, a new procedure for non-cancerous enlargement of the prostate, a very common condition in older men.

24 Sep 2018

New spinout company to tackle drug-resistant infections with novel antibiotics

Drug-resistant infections are set to kill more people than cancer by 2050. Now a new University of Plymouth spinout company has been established to help tackle the problem - by developing new antibiotics and bringing them to market.

24 Sep 2018

Innovation Fund Denmark supports research project that aims to fight Clostridium difficile diarrhea

One man's trash is another man's treasure, as the saying goes. If things go to plan, feces from registered and thoroughly tested healthy donors will in a few years be the standard treatment for the bacterium Clostridium difficile at Danish hospitals.

21 Sep 2018

Scientists use mice to study transmission of Lyme disease bacteria by infected ticks

Lyme borreliosis is a disease caused by bacteria of the genus Borrelia that are transmitted by a bite from a tick of the genus Ixodes.

21 Sep 2018

Overlooked immune cells could play a key role in cancer immunotherapy, claims new study

Cancer immunotherapy is a relatively new method of treating cancer and has succeeded with some refractory tumors. However, it doesn’t always work, why not?

21 Sep 2018

Scientist intends to fight pathogenic bacteria with viruses

Dr. Li Deng of Helmholtz Zentrum München has been awarded a Starting Grant of the European Research Council. The scientist intends to tackle antimicrobial resistance by fighting bacteria with their natural enemies - the viruses. The grant is endowed with nearly 1.5 million euros for five years.

21 Sep 2018

New research finds that MHC-II molecules have more influence on tumors than MHC-I

Cancer immunotherapy -- efforts to boost a patient's own immune system, allowing it to better fight cancer cells on its own -- has shown great promise for some previously intractable cancers.

21 Sep 2018

New naturally occurring antibiotic found effective against Mycobacterium tuberculosis

A naturally occurring antibiotic called kanglemycin A is effective against Mycobacterium tuberculosis, the bacteria that cause tuberculosis, even in drug-resistant strains, according to an international team of researchers who used chemistry, molecular biology, microbiology, and X-ray crystallography to show how the compound maintains its activity.

21 Sep 2018

Salk Institute researchers uncover molecular structure of RNA-based CRISPR system

Over the past several years, CRISPR-Cas9 has moved beyond the lab bench and into the public zeitgeist. This gene-editing tool CRISPR-Cas9 holds promise for correcting defects inside individual cells and potentially healing or preventing many human ailments.

20 Sep 2018

Scientists find wild African monkeys infected with bacterium that causes syphilis, yaws in humans

An international research team, led by scientists from the German Primate Center, the Robert Koch Institute, the Max Planck Institute for Evolutionary Anthropology, McGill University, Masaryk University, the University of Tübingen and the Max Planck Institute for the Science of Human History, has successfully recovered genomes of the bacterium Treponema pallidum, which causes syphilis and yaws in humans, from wild nonhuman primate populations across sub-Saharan Africa.

20 Sep 2018

Scientists achieve breakthrough in accelerated diagnosis of multi-resistant hospital pathogens

A team of researchers at the University of Cologne's Faculty of Medicine and the German Center for Infection Research has achieved a scientific breakthrough in the accelerated diagnosis of multi-resistant hospital pathogens.

20 Sep 2018

Finding epigenetic signature appears to predict inflammation risk in serious type of IBD

With an estimated 1.6 million people in the U.S. dealing with inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective.

20 Sep 2018

LineaRx signs agreement with Takis/Evvivax to develop linear-DNA based anti-cancer vaccines

Applied DNA Sciences Inc. announced today that LineaRx, Inc., its wholly-owned subsidiary focused on next-generation biotherapeutics, has signed a Joint Development Agreement with Takis S.R.L. and Evvivax S.R.L., biotechnology companies focused on the discovery and development of DNA based anti-cancer vaccines for the human and animal markets, respectively.

20 Sep 2018

Bacteria News and Research

Organs actively fighting back against autoimmune diseases, finds study

Blood-brain barrier can be important biomarker for early diagnosis of Alzheimer's disease

Genomic ‘islands’ evolved from viruses can be converted into ‘anti-bacterial drones’

Harmful H. pylori may play a role in Parkinson's disease

TU Wien develops new remedy for celiac disease

New test speeds up diagnosis of multi-resistant pathogens

Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD

Pioneering procedure for common prostate condition offered by The London Clinic

New spinout company to tackle drug-resistant infections with novel antibiotics

Innovation Fund Denmark supports research project that aims to fight Clostridium difficile diarrhea

Scientists use mice to study transmission of Lyme disease bacteria by infected ticks

Overlooked immune cells could play a key role in cancer immunotherapy, claims new study

Scientist intends to fight pathogenic bacteria with viruses

New research finds that MHC-II molecules have more influence on tumors than MHC-I

New naturally occurring antibiotic found effective against Mycobacterium tuberculosis

Salk Institute researchers uncover molecular structure of RNA-based CRISPR system

Scientists find wild African monkeys infected with bacterium that causes syphilis, yaws in humans

Scientists achieve breakthrough in accelerated diagnosis of multi-resistant hospital pathogens

Finding epigenetic signature appears to predict inflammation risk in serious type of IBD

LineaRx signs agreement with Takis/Evvivax to develop linear-DNA based anti-cancer vaccines

Microbiology eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo